Abstract
AbstractThe new μ3‐methoxido bridged trinuclear vanadium(IV) complexes [VIV3O3(μ3‐OMe)(μ2‐OMe)3(L1,2)2] (1 and 2) have been synthesized using the azo ligands 1‐(2‐(thiazol‐2‐yl)diazenyl)naphthalene‐2‐ol (HL1) and 2‐(2‐(thiazol‐2‐yl)diazenyl)‐4‐methylphenol (HL2). X‐ray crystallography revealed a trinuclear structure with a lacunary heterocubane {(VO)3(μ3‐OMe)(μ2‐OMe)3}2+ core unit for complex 1, which contains a central μ3‐methoxido bridge. All three vanadium centers are in a slightly distorted octahedral coordination environment. Magnetic and theoretical studies reveal an antiferromagnetic coupling between the three vanadium(IV) centers within the triangular arrangement in 1. The complexes were also screened for in vitro cytotoxicity study against HeLa and HT‐29 cancer cell lines. The results indicated that both the complexes are cytotoxic but possess varying specificity towards different cell types.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
